Donor cells tested to fight mysterious autoimmune disease
NCT ID NCT07061938
Summary
This early-stage study is testing a new cell therapy called ACE1831 for people with active IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues. The therapy uses immune cells (gamma delta T cells) from healthy donors. Researchers will give it to about 30 patients to check if it's safe and if it can put the disease into remission and prevent future flares.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4 RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kanazawa Medical University Hospital
RECRUITINGKahoku-gun, JP, 920-0293, Japan
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.